Evidence map›Paper›PMID 25618418›Full record

Trial reportEuropean journal of nutrition2016

Effects of increased wholegrain consumption on immune and inflammatory markers in healthy low habitual wholegrain consumers.

Antonios Ampatzoglou, Charlotte L Williams, Kiranjit K Atwal, Catherine M Maidens, Alastair B Ross, Frank Thielecke, Satya S Jonnalagadda, Orla B Kennedy, Parveen Yaqoob

Abstract readRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in European journal of nutrition, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 6 pooled it
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 6 syntheses or guidelines pooled it, 37 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Trial
  10. Article
  11. Review
  12. Analysis of the intricate effects of polyunsaturated fatty acids and polyphenols on inflammatory pathways in health and disease.Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association · 2020
    Review
  13. Chronic Inflammation in the Context of Everyday Life: Dietary Changes as Mitigating Factors.International journal of environmental research and public health · 2020
    Review
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 4 countries.

Antonios AmpatzoglouDepartment of Food and Nutritional Sciences and Institute of Cardiovascular and Metabolic Research, University of Reading, Reading, RG6 6AP, UK.
Charlotte L WilliamsDepartment of Food and Nutritional Sciences and Institute of Cardiovascular and Metabolic Research, University of Reading, Reading, RG6 6AP, UK.
Kiranjit K AtwalDepartment of Food and Nutritional Sciences and Institute of Cardiovascular and Metabolic Research, University of Reading, Reading, RG6 6AP, UK.
Catherine M MaidensDepartment of Food and Nutritional Sciences and Institute of Cardiovascular and Metabolic Research, University of Reading, Reading, RG6 6AP, UK.
Alastair B RossDepartment of Chemical and Biochemical Engineering, Chalmers University of Technology, 412 96, Gothenburg, Sweden.
Frank ThieleckeNestlé Research Centre, Nestec Ltd, Vers-chez-les-Blanc, 1000, Lausanne 26, Switzerland.
Satya S JonnalagaddaGeneral Mills Bell Institute of Health and Nutrition, 9000 Plymouth Ave N, Golden Valley, MN, 55427, USA.
Orla B KennedyDepartment of Food and Nutritional Sciences and Institute of Cardiovascular and Metabolic Research, University of Reading, Reading, RG6 6AP, UK.
Parveen YaqoobDepartment of Food and Nutritional Sciences and Institute of Cardiovascular and Metabolic Research, University of Reading, Reading, RG6 6AP, UK. p.yaqoob@reading.ac.uk.
University of Reading · GBEuropean Organization for Nuclear Research · CHGeneral Mills (United States) · USNestlé (Switzerland) · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeWholegrain (WG) consumption is associated with reduced risk of cardiovascular disease, but clinical data on inflammation and immune function is either conflicting or limited. The objective of this study was to assess the impact of increasing WG consumption to at least 80 g/day on markers of inflammation and glucose metabolism and on phenotypic and functional aspects of the immune system, in healthy, middle-aged adults with low habitual WG intake.

methodsSubjects consumed a diet high in WG (>80 g/day) or low in WG (<16 g/day, refined grain diet) in a crossover study, with 6-week intervention periods, separated by a 4-week washout. Adherence to the dietary regimes was achieved by dietary advice and provision of a range of food products, with compliance verified by analysis of plasma alkylresorcinols (ARs).

resultsOn the WG intervention, WG consumption reached 168 g/day (P < 0.001), accompanied by an increase in plasma ARs (P < 0.001) and fibre intake (P < 0.001), without affecting other aspects of dietary intake. On the WG arm, there were trends for lower ex vivo activation of CD4(+) T cells and circulating concentrations of IL-10, C-reactive protein, C-peptide, insulin and plasminogen activator inhibitor-1. The percentage of CD4(+) central memory T cells and circulating levels of adipsin tended to increase during the WG intervention.

conclusionsDespite the dramatic increase in WG consumption, there were no effects on phenotypic or functional immune parameters, markers of inflammation or metabolic markers.

Indexed as

Feeding BehaviorWhole GrainsAdultAgedBiomarkersBody Mass IndexCardiovascular DiseasesC-PeptideC-Reactive ProteinCross-Over StudiesDietDietary FiberFemaleHumansInsulinInterleukin-10BiomarkersC-PeptideC-Reactive ProteinDietary FiberIL10 protein, humanInsulinInterleukin-10Plasminogen Activator Inhibitor 1SERPINE1 protein, humanAlkylresorcinolsFibreImmuneInflammationWholegrain

Identifiers

PMID25618418
OpenAlexW2001858313

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.